NEAT1 modulates ATGL expression leading to disrupted lipolysis in HCC cells by augmenting miR‐124‐3p leading to promoted cancer progression (Liu et al., 2018b). This evidence concerns the gene NEAT1 and hepatocellular carcinoma.